Podcast Episodes
Back to SearchPerspectives on Maintenance Therapy in Small Cell Lung Cancer
Episode 555
Drs. Liu and Scott offer their perspectives on maintenance therapy in patients with small cell lung cancer, discussing the rationale, different appro…
1 year ago
Should clopidogrel replace aspirin as the standard for CAD prevention?
Episode 554
A large meta-analysis in The Lancet found clopidogrel superior to aspirin for long-term secondary prevention in coronary artery disease, reducing maj…
1 year ago
Treat to Target: What it Is and How to Implement
Episode 553
Drs. Chaichian and Dall’Era explore the “treat to target” approach in lupus, including key targets like DORIS remission and lupus low disease activit…
1 year ago
Earlier Use of Biologics for Treating Lupus
Episode 552
Drs. Dall’Era and Chaichian discuss earlier use of targeted biologics for treating lupus.
1 year, 1 month ago
Is FDA-backed elastography poised to replace biopsy as the driver of MASH drug development?
Episode 551
The FDA has endorsed vibration-controlled transient elastography as a surrogate endpoint for MASH trials, marking the first non-invasive alternative …
1 year, 1 month ago
2025 Guideline Summary for the Clinical Treatment and Management of Systemic Lupus Erythematosus
Episode 550
Drs. Chaichian and Dall’Era review the updated guidelines for the treatment and management of SLE in children and adults.
1 year, 1 month ago
Emerging Therapies in SLE: Recent Studies and Potential Game-Changing Treatments
Episode 549
Drs. Fava and Petri discuss emerging therapies in systemic lupus erythematosus, including treatments for lupus nephritis and cutaneous disease.
1 year, 1 month ago
Non-Invasive Biomarkers in SLE: A Promise of Better Diagnosis, Management, and Personalized Treatment?
Episode 548
Drs. Petri and Fava review non-invasive biomarkers in systemic lupus erythematosus, including urine proteomics.
1 year, 1 month ago
New Guidelines for the Screening, Treatment, and Management of Lupus Nephritis
Episode 547
Drs. Petri and Fava discuss updated guidelines for the screening, treatment, and management of lupus nephritis.
1 year, 1 month ago
What does FDA’s approval of generic liraglutide mean for obesity care?
Episode 546
The FDA has approved a generic version of liraglutide injection, expanding access to obesity treatment by lowering costs and broadening eligibility a…
1 year, 1 month ago